ArticleParasites & vectors2026
Comparison of two doxycycline dosages on inflammatory and stress response in dogs naturally infected with Dirofilaria immitis.
Article in Parasites & vectors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundCanine heartworm disease, caused by Dirofilaria immitis, is characterized by a marked inflammatory response largely driven by its endosymbiotic bacterium Wolbachia pipientis. Doxycycline is routinely incorporated into treatment protocols to reduce Wolbachia burden and the associated pathology. Although the standard recommended dosage is 10 mg/kg every 12 h for 28-30 days, evidence comparing lower dosages under clinical conditions remains limited. This study aimed to compare the effects of two doxycycline dosages on inflammatory and immune markers in dogs naturally infected with D. immitis during the pre-adulticidal phase of treatment.
methodsSeventy-seven dogs naturally infected with D. immitis were randomly allocated to receive doxycycline at either 10 mg/kg (n = 39) or 5 mg/kg (n = 38) every 12 h for 30 days, in combination with a single oral dose of ivermectin (6 µg/kg) administered at treatment initiation. Serum concentrations of C-reactive protein (CRP) and cortisol were measured at baseline (day 0) and after treatment completion (day 30). Anti-recombinant Wolbachia surface protein (rWSP) antibody levels were determined by ELISA. Intra- and intergroup comparisons were performed using non-parametric statistical tests.
resultsBoth doxycycline regimens resulted in a significant reduction in CRP concentrations from day 0 to day 30 (p < 0.05), indicating a decrease in systemic inflammation. No significant differences were observed between dosages in the magnitude of CRP reduction. Cortisol concentrations showed a non-significant downward trend in both groups, while anti-rWSP antibody levels remained stable throughout the study period. No significant intergroup differences were detected for any evaluated parameter.
conclusionsDoxycycline administered at 5 mg/kg every 12 h for 30 days showed a comparable short-term biomarker response to the standard 10 mg/kg regimen during the pre-adulticidal phase. Lower doxycycline dosages may represent a potential alternative with possible benefits in terms of tolerance, compliance, and antimicrobial stewardship, although these aspects were not directly evaluated in the present study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.